Secarna is a biopharmaceutical company. It develops LNAplus, a drug discovery platform for the production of antisense oligonucleotides. The company aims to develop antisense therapies specializing in the areas of immuno-oncology, ophthalmology, immunology, fibrotic diseases, and anti-viral applications.